Drug Database
Back to search

Poland· PL-100444410

Lumobry

A brimonidine product containing brimonidini tartras, registered in Poland by Bausch+Lomb Ireland Ltd.. The same ATC class is registered in 7 of our 19 countries.

ATC S01GA07

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedLumobryATCS01GA07REGISTER NO.PL-100444410PACKS LISTED1CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about brimonidini tartrasAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Brimonidine is registered in 7 of 19 countries.

Countries holding a registration under ATC S01GA07 (brimonidine), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 5 of them publish a price we can compare per daily dose
Search brimonidine products by name

Brimonidine · ATC S01GA07

7 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Italyprice
  • Netherlands
  • Polandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

URPL (Poland)
Active substance
Brimonidini tartras
Manufacturer
Bausch+Lomb Ireland Ltd.
Country
Poland (PL)
ATC code
S01GA07
ATC class
Brimonidine
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 1

  • gtin
    05397258001206

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

567 interactions on record for brimonidine.

Graded by severity as the source publishes them — 387 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check brimonidine against other medicinesHow interaction checks work

Brimonidine · interactions on record

567 records

  • 387 moderate
  • 180 info

Most severe, free to view

  • PapaverineA03AD01moderate
  • MetoclopramideA03FA01moderate
  • DimenhydrinatA04AB02moderate
  • ThiethylperazinA04AB03moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Brimonidine in 17 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All brimonidine products

Authorised across Europe · EMA

The same active substance is authorised in 29 EEA countries. Names it is sold under:

  • Austria · Alpha-Vision Sine, Alphagan
  • Belgium · Alphagan, Lumobry
  • Bulgaria · Brimogen, Бримонидин Абр
  • Cyprus · Brimontal, Corneax
  • Czechia · Alphagan, Brimonidin Olikla
  • Germany · Alphagan, Brimo-Vision
  • Denmark · Alphagan, Brimonidintartrat 1a Farma
  • Spain · Abradel, Alphagan
  • Finland · Alphagan, Lumobry
  • France · Alphagan, Brimazed
  • United Kingdom (Northern Ireland) · Alphagan, Brimonidine Omnivision
  • Greece · Alphagan, Brimofree
  • Croatia · Alphagan, Bimanox
  • Hungary · Brimogen, Lumobry
  • Ireland · Alphagan, Lumobry
  • Iceland · Alphagan, Brimonidin Bluefish
  • Italy · Alphagan, Brimofree
  • Liechtenstein · Mirvaso
  • Lithuania · Brimonal, Brimonidine Tartrate Elvim
  • Luxembourg · Alphagan, Brimonidin Micro Labs
  • Latvia · Briglafre, Brimonal
  • Malta · Alphagan, Brimogan
  • Netherlands · Alphagan, Brimonidine Stulln
  • Norway · Alphagan, Brymont
  • Portugal · Alphagan, Bglau
  • Romania · Brimonal 2 Mg/Ml, Brimonidină Rompharm
  • Sweden · Alphagan, Brimonidin Bluefish
  • Slovenia · Bimanox, Luvify
  • Slovakia · Brimonal, Brimonidin Olikla

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/a3645a85-8232-4228-9523-d5533185cb44
GET /v1/drugs/a3645a85-8232-4228-9523-d5533185cb44?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Krople do oczu, roztwór",
  "source": "urpl",
  "strength": "0,25 mg/ml",
  "packaging": "05397258001206 ¦ Rp ¦ 149872\n1 butelka 7,5 ml",
  "substance": "Brimonidini tartras 0.25 mg/ml",
  "common_name": "Brimonidini tartras",
  "pl_product_id": "100444410",
  "pozwolenie_nr": "27815",
  "auth_procedure": "DCP",
  "authorisation_validity": "2028-05-08"
}
API referenceMCP serverPlans

See everything about brimonidine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console